NCT02651155 Lubiprostone for the Treatment of Chronic Idiopathic Constipation Status COMPLETED Phase PHASE3
NCT02646683 A Study to Evaluate Efficacy, of Early Versus Late Use of Vedolizumab in Crohn's Disease: the LOVE-CD Study Status COMPLETED Phase PHASE4
NCT02646657 An Open Label Phase 4 Study to Evaluate Efficacy of Early Versus Late Use of Vedolizumab in Ulcerative Colitis Status COMPLETED Phase PHASE4
NCT02637466 Vortioxetine for MDD, Cognition, and Systemic Inflammatory Biomarkers Status WITHDRAWN Phase PHASE4
NCT02630966 Vedolizumab IV 300 mg in the Treatment of Fistulizing Crohn's Disease Status COMPLETED Phase PHASE4
NCT02630030 Phase 0 Analysis of Ixazomib (MLN9708) in Patients With Glioblastoma Status COMPLETED Phase EARLY_PHASE1
NCT02629848 Study of Motesanib (AMG 706) in Combination With Paclitaxel and Carboplatin for Advanced Non-Squamous Non-Small Cell Lung Cancer Status TERMINATED Phase PHASE3
NCT02622581 Clinical Research Platform Into Molecular Testing, Treatment and Outcome of (Non-)Small Cell Lung Carcinoma Patients Status RECRUITING Phase N/A
NCT02620046 A Study of Long-term Effects of Vedolizumab Subcutaneous in Adults With Ulcerative Colitis and Crohn's Disease Status COMPLETED Phase PHASE3
NCT02616315 Efficacy of Naltrexone HCl/Bupropion HCl Extended Release Versus Placebo for Treatment of Weight Regain in Participants Post Bariatric Surgery Status WITHDRAWN Phase PHASE4
NCT02616302 A Study to Check the Safety of Dexlansoprazole and Learn if it Can Treat Symptomatic Nonerosive Gastroesophageal Reflux Disease in Children 2 to 11 Years Old Status COMPLETED Phase PHASE2
NCT02615184 A Study to Check the Safety of Dexlansoprazole and Learn If it Can Heal Erosive Esophagitis (EE) and Keep it Healed in Children 2 to 11 Years Old Status TERMINATED Phase PHASE2
NCT02614586 Evaluation of TAK-058 and Ondansetron on P50 Auditory Gating in Participants With Stable Schizophrenia Status TERMINATED Phase PHASE1
NCT02613221 A Phase I/II Study for the Safety and Efficacy of Panitumumab in Combination With TAS-102 for Patients With Colorectal Cancer Status COMPLETED Phase PHASE1/PHASE2
NCT02611830 Efficacy and Safety of Vedolizumab Subcutaneously (SC) as Maintenance Therapy in Ulcerative Colitis Status COMPLETED Phase PHASE3
NCT02611817 Efficacy and Safety of Vedolizumab Subcutaneous (SC) as Maintenance Therapy in Crohn's Disease (CD) Status COMPLETED Phase PHASE3
NCT02584569 Phase 1 TAK-915 Single-Dose Positron Emission Tomography (PET) Occupancy Study Status COMPLETED Phase PHASE1
NCT02566759 A TAK-831-1001, Single and Multiple Rising Dose Study in Healthy Participants Status TERMINATED Phase PHASE1
NCT02561156 TAK-653 Escalating Single and Multiple Dose Study in Healthy Participants Status COMPLETED Phase PHASE1